Trial Profile
Pharmacokinetics of single dose of APL-130277 in healthy volunteers and compare the bioavalability between the formulations used in study CTH-105 and the scaled up formulation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jul 2017
Price :
$35
*
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 27 Jul 2017 New trial record
- 27 Jun 2017 Results presented at the 3rd Congress of the European Academy of Neurology